Reaktionsgleichung
[C:1]([C:5]1[CH:18]=[CH:17][C:8]([O:9][CH2:10][C@H:11]2[O:15][C:14]([NH2:16])=[N:13][CH2:12]2)=[CH:7][CH:6]=1)([CH3:4])([CH3:3])[CH3:2].C([O:21][C:22](=O)[CH:23]([CH:26]=O)[CH2:24][CH3:25])C>C(Cl)(Cl)Cl>[C:1]([C:5]1[CH:18]=[CH:17][C:8]([O:9][CH2:10][CH:11]2[O:15][C:14]3=[N:16][C:22](=[O:21])[C:23]([CH2:24][CH3:25])=[CH:26][N:13]3[CH2:12]2)=[CH:7][CH:6]=1)([CH3:4])([CH3:2])[CH3:3]Komponenten
4
Versuchsvorschrift
The title compound was prepared from (S)-5-(4-tert-butyl-phenoxymethyl)-4,5-dihydro-oxazol-2-ylamine and 2-formyl-butyric acid ethyl ester employing the procedure described in Step2 of Example 87. [α]D25 −31.20 (c 0.5, CHCl3).
Quellen und Nachweise
- ORD-Eintrag
- ord-2a1325e2405746c6bec9718275e8c03c
- Quelldatensatz
- uspto-grants-2014_02
- Patentnummer
- US08642603B2
Verknüpfte Notizen
Wird geladen…